What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Steven A. Krilis focuses on Beta 2-Glycoprotein I, Molecular biology, Immunology, Antiphospholipid syndrome and Internal medicine.
His Beta 2-Glycoprotein I study contributes to a more complete understanding of Antibody.
His research in Antibody intersects with topics in Radioimmunoassay and Antigen.
The concepts of his Immunology study are interwoven with issues in Matrix metalloproteinase and Disease.
The Antiphospholipid syndrome study combines topics in areas such as Autoantibody, Vascular disease and Pathogenesis.
The concepts of his Anti-cardiolipin antibodies study are interwoven with issues in Antiphospholipid antibody positivity, Medical physics and Catastrophic antiphospholipid syndrome.
His most cited work include:
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). (4564 citations)
- Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). (1463 citations)
- Immunology and clinical importance of antiphospholipid antibodies. (427 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Antibody, Antiphospholipid syndrome, Beta 2-Glycoprotein I and Molecular biology.
His Antibody study integrates concerns from other disciplines, such as Platelet, Phospholipid, Antigen and Virology.
His Antigen research is multidisciplinary, incorporating perspectives in Allergen and House dust mite.
His Antiphospholipid syndrome study combines topics in areas such as Lupus anticoagulant, Clinical trial and Intensive care medicine.
His study on Beta 2-Glycoprotein I also encompasses disciplines like
- Biochemistry which intersects with area such as Thrombin,
- Beta that intertwine with fields like Cardiolipin.
His studies deal with areas such as Mast cell, Phospholipid Binding, Protease, Receptor and Epitope as well as Molecular biology.
He most often published in these fields:
- Immunology (52.11%)
- Antibody (31.92%)
- Antiphospholipid syndrome (23.94%)
What were the highlights of his more recent work (between 2010-2020)?
- Immunology (52.11%)
- Antiphospholipid syndrome (23.94%)
- Beta 2-Glycoprotein I (25.82%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Immunology, Antiphospholipid syndrome, Beta 2-Glycoprotein I, Internal medicine and Antibody.
Steven A. Krilis frequently studies issues relating to Pharmacology and Immunology.
His Antiphospholipid syndrome research is multidisciplinary, relying on both Core laboratory, Autoimmune disease, Clinical trial and Lupus anticoagulant.
Steven A. Krilis has researched Beta 2-Glycoprotein I in several fields, including Oxidative stress, Biochemistry, Pathogenesis, Inflammation and Immune system.
The various areas that Steven A. Krilis examines in his Internal medicine study include Endocrinology and Cardiology.
His biological study spans a wide range of topics, including Troponin, Platelet, Apoptosis and Ischemia.
Between 2010 and 2020, his most popular works were:
- The Pathogenesis of the Antiphospholipid Syndrome (418 citations)
- Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies (351 citations)
- Essential role for mast cell tryptase in acute experimental colitis (98 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Steven A. Krilis mainly investigates Immunology, Antiphospholipid syndrome, Beta 2-Glycoprotein I, Autoantibody and Colitis.
His Immunology study combines topics from a wide range of disciplines, such as Posttranslational modification, Heparan sulphate and Age related.
His Antiphospholipid syndrome research incorporates themes from Lupus anticoagulant and Rheumatology.
His Beta 2-Glycoprotein I study improves the overall literature in Antibody.
In his study, Abortion, MEDLINE, Immunity, Obstetrical complications and Disease mechanisms is strongly linked to Pathogenesis, which falls under the umbrella field of Autoantibody.
His work deals with themes such as Proinflammatory cytokine and Molecular biology, which intersect with Colitis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
